Literature DB >> 2122238

Altered transcriptional activity of c-fos promoter plasmids in v-raf-transformed NIH 3T3 cells.

Z Siegfried1, E B Ziff.   

Abstract

In cells transformed by v-raf, an oncogenic counterpart of the serine/threonine kinase Raf-1, regulatory elements of the c-fos promoter were active under conditions of cell growth or stimulation for which they were inactive in untransformed control cells. This suggests that v-raf transforms by deregulating transcription of early response genes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122238      PMCID: PMC361409          DOI: 10.1128/mcb.10.11.6073-6078.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences.

Authors:  R Treisman
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

2.  Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression.

Authors:  M Z Gilman; R N Wilson; R A Weinberg
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

3.  The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation.

Authors:  V M Rivera; M Sheng; M E Greenberg
Journal:  Genes Dev       Date:  1990-02       Impact factor: 11.361

4.  Mutation of the c-fos gene dyad symmetry element inhibits serum inducibility of transcription in vivo and the nuclear regulatory factor binding in vitro.

Authors:  M E Greenberg; Z Siegfried; E B Ziff
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

5.  Stable transfer and restricted expression of a cloned class I gene encoding a secreted transplantation-like antigen.

Authors:  Y Barra; K Tanaka; K J Isselbacher; G Khoury; G Jay
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

6.  Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors.

Authors:  R Treisman
Journal:  Cell       Date:  1986-08-15       Impact factor: 41.582

7.  Structure and biological activity of human homologs of the raf/mil oncogene.

Authors:  T I Bonner; S B Kerby; P Sutrave; M A Gunnell; G Mark; U R Rapp
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

8.  Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.

Authors:  U R Rapp; M D Goldsborough; G E Mark; T I Bonner; J Groffen; F H Reynolds; J R Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Expression of c-fos in NIH3T3 cells is very low but inducible throughout the cell cycle.

Authors:  R Bravo; J Burckhardt; T Curran; R Müller
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

10.  Requirement for c-ras proteins during viral oncogene transformation.

Authors:  M R Smith; S J DeGudicibus; D W Stacey
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  5 in total

1.  Functional analysis of an isolated fos promoter element with AP-1 site homology reveals cell type-specific transcriptional properties.

Authors:  A Velcich; E B Ziff
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Raf-1 protein expression in human breast cancer cells.

Authors:  L S Callans; H Naama; M Khandelwal; R Plotkin; L Jardines
Journal:  Ann Surg Oncol       Date:  1995-01       Impact factor: 5.344

3.  Biochemical analysis of torso and D-raf during Drosophila embryogenesis: implications for terminal signal transduction.

Authors:  F Sprenger; M M Trosclair; D K Morrison
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

4.  Serum-dependent transcriptional networks identify distinct functional roles for H-Ras and N-Ras during initial stages of the cell cycle.

Authors:  Esther Castellano; Carmen Guerrero; Alejandro Núñez; Javier De Las Rivas; Eugenio Santos
Journal:  Genome Biol       Date:  2009-11-06       Impact factor: 13.583

5.  Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.

Authors:  Y Shimizu; I Kinoshita; J Kikuchi; K Yamazaki; M Nishimura; M J Birrer; H Dosaka-Akita
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.